A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

Bibliographic Details
Main Authors: Rutgeerts, Paul J, Fedorak, Richard N, Hommes, Daan W, Sturm, Andreas, Baumgart, Daniel C, Bressler, Brian, Schreiber, Stefan, Mansfield, John C, Williams, Marna, Tang, Meina, Visich, Jennifer, Wei, Xiaohui, Keir, Mary, Luca, Diana, Danilenko, Dimitri, Egen, Jackson, O'Byrne, Sharon
Format: Online
Language:English
Published: BMJ Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711369/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711369/

Similar Items